Amgen Net Profit Rises, Key Drug Meets Goal
NEW YORK/LOS ANGELES, July 26 (Reuters) - Amgen Inc. on Thursday posted quarterly profit that topped Wall Street expectations, even as sales of its biggest drug, Aranesp, fell 19 percent in the United States amid safety concerns.